4/A
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001104659-20-029693
Options or other derivatives
- President and CEO acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
CARUSO JAMES V · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-03 | Grant or award : show line 1 in the form Stock option (right to buy) | +100,000 | 100,000 | D |
Loading xslF345X03/tm2011832d3_4a.xml…